Please read and agree to the terms and conditions of this site.
@xconomy.com 7 months ago
Bio Roundup: CRISPR Kudos, Bristol Myers’s Buy, RNAi Alliance & More
@xconomy.com 7 months ago
Bio Roundup: MESO’s Miss, Pfizer’s Cancer Bet, Vaccine Promise & More
@xconomy.com 7 months ago
Bio Roundup: MESO’s Miss, Pfizer’s Cancer Bet, Vaccine Promise & More
@xconomy.com 7 months ago
Bio Roundup: SeaGen Scores, Dyne’s Debut, Microbiome Moves & More
@xconomy.com 8 months ago
Biofourmis Hauls In $100M to Scale Digital Therapeutics Globally
@xconomy.com 9 months ago
AbbVie Exits Editas Alliance, Pruning Another Genetic Medicines Pact
@digitaltrends.com 9 months ago
How to watch Scrubs online: Binge the iconic medical sitcom for free
@xconomy.com 9 months ago
Two Days, Six IPOs, and $1B Raised for Biotech Research & More
@xconomy.com 9 months ago
Roche, Blueprint Medicines Team Up Again in $775M RET Cancer Drug Pact
@xconomy.com 11 months ago
CereVasc Lands $44M for New Medical Device to Drain “Water on the Brain”
@xconomy.com 11 months ago
HotSpot Therapeutics Adds $65M to Steer Allosteric Medicines to the Clinic
@xconomy.com 1 year ago
Lyra Therapeutics IPO Raises $56M for Tests of Tech for Runny Noses
@xconomy.com 1 year ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com 1 year ago
Revolution Medicines IPO Reels In $238M to Take On RAS in Cancer
@xconomy.com 1 year ago
CRISPR, CAR-T, Consolidation: Top Advanced Therapy Milestones of 2019
@xconomy.com 1 year ago
With $45M, Mammoth Bio Expects Big Things From Tiny CRISPR Cas14
@xconomy.com 1 year ago
Roche Puts Up Historic $1.15B for Sarepta Duchenne Gene Therapy Deal
@xconomy.com 1 year ago
Veracyte Aims to Expand Diagnostics Reach With $50M NanoString Deal
@xconomy.com 1 year ago
Novartis to Acquire MedCo and FDA-Ready Cholesterol Drug for $9.7B
@xconomy.com 1 year ago
Stryker Adds to Trauma & Extremities Biz With $4B Wright Medical Deal
@xconomy.com 1 year ago
Roche to Pay Dicerna Pharma $200M to Team Up on Hepatitis B Drug
@xconomy.com 1 year ago
Bio Roundup: Ichnos Emerges, Beyond CAR-T, BridgeBio Bails & More
@xconomy.com 1 year ago
UCB Stakes Out Autoimmune Territory With $2.1B Deal for Ra Pharma
@xconomy.com 1 year ago
Five Years After Y Combinator First Admits Biotechs, They’re Dug In
@xconomy.com 1 year ago
Flagship’s Omega Aims to Take Epigenetic Drugs a Step Further
@xconomy.com 1 year ago
SpringWorks and Satsuma Boost This Week’s Biotech IPO Haul to $595M
@xconomy.com 1 year ago
Frequency Plans IPO for Hearing Loss Drug & More Regenerative Meds
@engadget.com 1 year ago
Wirecutter's best deals: Save $300 on a Google Pixel 3
@xconomy.com 1 year ago
Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More
@xconomy.com 1 year ago
Spine-Surgery Medtech Startup Carlsmed Merges With Imaging Company
@xconomy.com 1 year ago
Bio Roundup: Michael Becker, Suzanne Eaton, Gene Therapy Moves & More
@xconomy.com 1 year ago
WI Watchlist: Microsoft, Exact Sciences, Shine & MKE Tech Hub
@xconomy.com 1 year ago
Providence St. Joseph to Buy Wisconsin Health IT Consultant Bluetree
@xconomy.com 1 year ago
PanTheryx Lands $50M to Use “First Milk” to Target Gut Microbiome
@xconomy.com 1 year ago
Encoded Nabs $104M, Illumina’s Help, to Push Gene Therapy’s Limits
@xconomy.com 1 year ago
Boston Tech Watch: Polaris, GE, DataRobot, Facial Recognition Woes
@xconomy.com 1 year ago
Invitae Offers $55M for Singular Bio to Expand Prenatal Test Business
@xconomy.com 1 year ago
Synlogic Lands $80M from Ginkgo to Ramp Up “Living Medicines” R&D
@xconomy.com 1 year ago
WI Watchlist: Montage, LÜM, WEDC, Titan Spine, Polco, Swallow & More
@xconomy.com 1 year ago
Bio Roundup: Generic Drugs Graft, ASCO Ahead, ElevateBio Rises & More
@xconomy.com 1 year ago
Seattle’s TransformativeMed Carves Out Niche in Medical Specialties
@xconomy.com 2 years ago
Meet the Xconomy Awards San Diego Digital Trailblazer Finalists
@xconomy.com 2 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@xconomy.com 2 years ago
NorthStar Secures $75M+ as Medical Radioisotope Competition Revs Up
@xconomy.com 2 years ago
Bardy Diagnostics to Ramp Up Cardiac Monitor Sales With $35M Raise
@xconomy.com 2 years ago
Bio Roundup: Amyloid Angst, NASH News, Brammer Bagged & More
@xconomy.com 2 years ago
Xealth Gets $11M, Aims to Be Surescripts of Digital Health Services
@xconomy.com 2 years ago
CRISPR Diagnostic Race Heats Up as Sherlock Bio Launches With $35M